Organization | Biopolis S.L.

Biopolis S.L. Report issue

For profit Phase 2 Phase 3

Founded: Valencia Spain (2003)

Status: No NME R&D (2003)

Organization Overview

First Clinical Trial

2015

NCT02576197

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Now

Alternative names

Biopolis S.L.

Active Ingredients

Drugs in Phase 3 Trials (2)

bifidobacterium animalis (2 trials)

inactivated probiotic (1 trial)

Drugs in Phase 2 Trials (4)

bifidobacterium longum (2 trials)

lactobacillus casei (1 trial)

lactobacillus rhamnosus (1 trial)

maltodextrin (2 trials)

Drugs in Other Trials (2)

lactobacillus delbrueckii (2 trials)

whey protein (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Dyspepsia (Phase 2)

Obesity (Phase 3)

Signs and Symptoms (Phase 2)

Signs and Symptoms, Digestive (Phase 2)

Overview

Highest Phase: Phase 3
# of Trials: 7
# of Trial APIs: 8